Literature DB >> 30016488

Atherosclerosis and renal disease involvement in patients with systemic lupus erythematosus: a cross-sectional cohort study.

Marie-Louise Hermansen1, Benjamin Sandholt2, Andreas Fuchs3, Henrik Sillesen2, Lars Køber3, Klaus Fuglsang Kofoed3,4, Mikkel Faurschou1, Søren Jacobsen1.   

Abstract

Objective: To investigate the association between LN, renal function and atherosclerosis measured by coronary artery calcium (CAC) and carotid plaque in a cross-sectional study of patients with SLE.
Methods: Presence of CAC and carotid plaque was measured in 147 SLE patients with and without LN. The patients were divided into four groups according to LN and renal function [by first quartile of estimated glomerular filtration rate (eGFR): 70 ml/min/1.73 m2]. Impaired renal function was defined by an eGFR <70 ml/min/1.73 m2. We used multivariate logistic regression models to explore the association between LN, renal function, CAC and carotid plaque.
Results: Of the 147 SLE patients, 74 had LN. Median age of the study cohort was 46 years, 89% were women and median eGFR was 89 ml/min/1.73 m2. CAC score >0 was present in 57 (39%) and carotid plaque in 29 (20%) of the SLE patients. The presence of CAC and/or carotid plaque was highest in SLE patients with impaired renal function. Regression analyses showed that compared with SLE patients without LN and eGFR ⩾70 ml/min/1.73 m2 (reference group), only the combination of LN and impaired renal function was associated with the presence of CAC (odds ratio: 6.82, 95% CI: 1.59, 29; P = 0.01) and carotid plaque (odds ratio: 5.60, 95% CI: 1.19, 26; P = 0.03).
Conclusion: Our findings indicate that LN in combination with impaired renal function defined by an eGFR <70 ml/min/1.73 m2 is strongly associated with the presence of atherosclerosis in SLE.

Entities:  

Mesh:

Year:  2018        PMID: 30016488     DOI: 10.1093/rheumatology/key201

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs.

Authors:  Genhong Yao; Jingjing Qi; Xiaojing Li; Xiaojun Tang; Wenchao Li; Weiwei Chen; Nan Xia; Shiying Wang; Lingyun Sun
Journal:  Stem Cell Res Ther       Date:  2022-07-18       Impact factor: 8.079

2.  Cardiovascular Manifestations of Systemic Sclerosis: A Danish Nationwide Cohort Study.

Authors:  Sheraz A Butt; Jørgen L Jeppesen; Christian Torp-Pedersen; Flora Sam; Gunnar H Gislason; Søren Jacobsen; Charlotte Andersson
Journal:  J Am Heart Assoc       Date:  2019-08-24       Impact factor: 5.501

3.  Coronary artery disease (CAD) risk factor analysis in an age-stratified hospital population with systemic lupus erythematosus (SLE).

Authors:  Dennis J Levinson; Ashraf Abugroun; Hussein Daoud; Manar Abdel-Rahman
Journal:  Int J Cardiol Hypertens       Date:  2020-10-14

4.  Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Role of Fibroblast Growth Factor 23- Phosphate Axis.

Authors:  Yaser Ammar; Amira Mohamed; Gihane Khalil; Dalia Maharem
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-08-27

5.  Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus.

Authors:  Amanda Hempel Zinglersen; Katrine Kjær Iversen; Henrik Christian Bidstrup Leffers; Esben Laugesen; Jesper Fleischer; Søren Jacobsen
Journal:  Lupus Sci Med       Date:  2021-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.